Program development
Program development for this event has required a wide range of contributors from hospital pharmacy to industrial manufacture to CMC and regulatory. We greatly appreciate the time the following individuals have put in to brain storming, program refining and contacting/confirming speakers.
We are very proud of the program we have developed together!
- Miriam Idar and Gunilla Andrew-Nielsen (LV),
- Silke Klick, Anna Collén (AstraZeneca),
- Kenneth Chien (KI),
- Matti Sällberg (KI),
- Margareth Jorvid (Methra Uppsala AB),
- Anna Ridderstad Wollberg (RISE),
- Eva-Karin Gidlund (NorthX Biologics),
- Seppo Yla Herttuala (FinVector),
- Samir el Andaloussi (KI),
- Thomas Eldered (Flerie Invest),
- Sara Riggare (Forum Spetspatient),
- Johan Rockberg (KTH),
- Mikael Kubista (TATAA Biocenter),
- Andreas Palmborg (Pfizer),
-
Marcus Wilhelmsson (Chalmers University of Technology, FoRmulaEx),
- Hans-Gustaf Ljunggren (NextGenNK),
- Evren Alici (KI),
- Jens Bäck (Svenska Vaccinfabriken production AB),
- Janet Hoogstraate (Valneva),
- Kristina Kannisto (ATMP Sweden),
- Pontus Blomberg (CAMP/KCC/KUH),
- Mats Jarekrans (Vinnova),
- Margaretha Tennander, Jesper Hedberg (Cytiva),
- Frida Lundmark, Dag Larsson, Annakarin Svenningsson (LIF),
- Ebba Carbonnier (Swelife),
- Sharon Jåma (Sveriges Radio),
- Lars Frelin (Karolinska Institutet),
- Aud Jorunn Sølvberg (Sjukhusapoteksfunktionen Region Stockholm),
- Manólis Nymark (Nymark Consulting)